It is characterized by recurrent episodes of consuming large quantities of food in a discrete period, accompanied by a sense of loss of control and marked distress
Cai HY, Hlscher C, Yue XH, et al
Clinical implication The updated FDA labeling for liraglutide and semaglutide highlights the importance of monitoring depressive symptoms or suicidal thoughts, suggesting treatment discontinuation if such ideations occur [87,88]
The program may provide prescription access, medication coordination and continuing provider support for eligible customers
That collaboration was one reason why GEN selected Nimbus among its Ten Companies to Watch in AI Drug Discovery, an A-List published in November 2024
Depression and risk of developing dementia